85 studies found for:    L-FAC
Show Display Options
Rank Status Study
1 Completed The Biodistribution of 1-L-(2 Deoxy-2,- 18 Fluoroarabinofuranosyl) Cytosine ([18F]L-FAC) in Healthy Subjects and Patients With Cancer, Autoimmune and Inflammatory Diseases
Conditions: Autoimmune Diseases;   Cancer
Intervention:
2 Recruiting A Phase III Study of 2nd-line XELIRI ± Bevacizumab vs. FOLFIRI ± Bevacizumab in mCRC
Conditions: Colorectal Neoplasms;   Neoplasm Metastasis;   Intestinal Neoplasms;   Gastrointestinal Neoplasms;   Digestive System Neoplasms
Interventions: Biological: Bevacizumab;   Drug: CPT-11 (Irinotecan);   Drug: 5-FU Bolus;   Drug: 5-FU Infusion;   Drug: l-LV (dl-LV);   Biological: bevacizumab;   Drug: Capecitabine
3 Completed Effect of Thermal Stimulation for Lower Extremity Movement and Function in Patients With Stroke
Condition: Stroke
Intervention: Other: thermal stimulation
4 Recruiting Achievement of Improved Survival by Molecular Targeted Chemotherapy and Liver Resection for Not Optimally Resectable Colorectal Liver Metastases
Condition: Liver Only Metastasis From KRAS Wild Type Colorectal Cancer
Interventions: Drug: Bevacizumab;   Drug: Cetuximab;   Drug: L-OHP;   Drug: l-LV;   Drug: 5-FU
5 Recruiting Exploratory Study in Achievement of Improved Survival by Molecular Targeted Chemotherapy and Liver Resection for Not Optimally Resectable Colorectal Liver Metastases
Condition: Liver Only Metastasis From Colorectal Cancer ( KRAS Wild-type )
Interventions: Drug: Bevacizumab;   Drug: Cetuximab;   Drug: L-OHP;   Drug: l-LV;   Drug: 5-FU
6 Recruiting Immunotherapy Study in Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer
Conditions: Pancreatic Cancer;   Pancreatic Carcinoma Non-resectable;   Locally Advanced Malignant Neoplasm
Interventions: Drug: FOLFIRINOX;   Biological: Algenpantucel-L Immunotherapy;   Radiation: 5-FU Chemoradiation;   Drug: Gemcitabine;   Drug: Capecitabine;   Drug: Nab-Paclitaxel
7 Completed NY-ESO-1 Protein With Montanide and CpG 7909 as Cancer Vaccine in Several Tumors
Condition: Tumors
Intervention: Biological: NY-ESO-1 protein with CpG 7909 and Montanide
8 Not yet recruiting Endogenous Progenitors Cell Therapy for Diabetic Foot Ulcers
Condition: Diabetic Ulcer
Intervention: Drug: AMD3100 injection + rhPDGF-BB topical
9 Active, not recruiting Study of the Combination of Rituximab, Cyclophosphamide, Doxorubicin, VELCADE, and Prednisone or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Newly Diagnosed Mantle Cell Lymphoma
Condition: Mantle Cell Lymphoma
Interventions: Drug: Rituximab;   Drug: Cyclophosphamide;   Drug: Doxorubicin;   Drug: VELCADE;   Drug: Prednisone;   Drug: Vincristine
10 Not yet recruiting Study of CO2 Exchange Patterns During Robotic Prostatectomies
Conditions: Prostate Cancer;   Pneumoperitoneum
Interventions: Device: AirSeal System;   Device: Standard Endopath
11 Recruiting Prevention of Lymphoceles After Robotic PLND
Conditions: Lymphoceles;   Prostate Cancer
Intervention: Device: Intuitive Vessel Sealer
12 Terminated Open-Label, Long-Term Treatment Study, to Assess the Long-Term Safety and Tolerability and Efficacy of Neramexane in Patients With Subjective Tinnitus
Condition: Subjective Tinnitus
Intervention: Drug: Neramexane mesylate
13 Completed Responses to Influenza Vaccine in Patients With Mitochondrial Disorders (MELAS)
Condition: MELAS Syndrome
Intervention: Biological: Intramuscular seasonal trivalent inactivated influenza vaccine
14 Not yet recruiting Comparison of Processed Nerve Allograft and Collagen Nerve Cuffs for Peripheral Nerve Repair
Condition: Peripheral Nerve Discontinuities
Interventions: Biological: Processed Nerve Allograft (human);   Device: Collagen Nerve Cuff
15 Unknown  BENEFIT: Evaluation of the Use of Antiparasital Drug (Benznidazole) in the Treatment of Chronic Chagas' Disease
Conditions: Chagas Disease;   Trypanosomiasis;   Heart Disease
Interventions: Drug: Benznidazole;   Drug: Placebo
16 Completed Radiation Therapy With or Without Radiosurgery in Treating Patients With Brain Metastases
Condition: Metastatic Cancer
Interventions: Procedure: surgical procedure;   Radiation: radiation therapy;   Radiation: stereotactic radiosurgery
17 Recruiting Intraperitoneal Chemotherapy and Systemic Chemotherapy Versus Systemic Chemotherapy After Curative Resection of Serosa-positive Gastric Cancer
Condition: Advanced Gastric Cancer With Serosal Invasion
Interventions: Procedure: surgery;   Drug: adjuvant systemic chemotherapy;   Drug: Early postoperative intraperitoneal chemothgerapy
18 Completed Chemotherapy Plus Radiation Therapy Followed by Surgery in Treating Patients With Soft Tissue Sarcoma
Condition: Sarcoma
Interventions: Biological: filgrastim;   Drug: dacarbazine;   Drug: doxorubicin hydrochloride;   Drug: ifosfamide;   Drug: mesna;   Procedure: conventional surgery;   Radiation: brachytherapy;   Radiation: intraoperative radiation therapy;   Radiation: radioisotope therapy
19 Completed Safety and Efficacy of Talactoferrin in Previously Treated Patients With Non-small Cell Lung Cancer
Condition: Non Small Cell Lung Cancer
Interventions: Drug: Talactoferrin;   Drug: Placebo
20 Completed Monoclonal Antibody Therapy (Rencarex®) in Treating Patients Who Have Undergone Surgery for Non-metastatic Kidney Cancer
Condition: Kidney Cancer
Interventions: Biological: girentuximab;   Other: placebo

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years